Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: AN2 Therapeutics Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
AN2 Therapeutics Inc. June 3, 202690.9%
-
AN2 Therapeutics Inc. June 7, 202394.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 9, 2026 | AN2 Therapeutics Inc. | Open-market sale | −523 | $6.02 | $3,148 |
| Sep 9, 2026 | AN2 Therapeutics Inc. | Open-market sale | −585 | $6.02 | $3,522 |
| Sep 8, 2026 | AN2 Therapeutics Inc. | Open-market sale | −4,725 | $6.02 | $28,445 |
| Sep 8, 2026 | AN2 Therapeutics Inc. | Open-market sale | −5,294 | $6.02 | $31,870 |
| Sep 3, 2026 | AN2 Therapeutics Inc. | Open-market sale | −2,877 | $6.07 | $17,463 |
| Sep 3, 2026 | AN2 Therapeutics Inc. | Open-market sale | −3,223 | $6.07 | $19,564 |
| Aug 17, 2026 | AN2 Therapeutics Inc. | Open-market sale | −16,696 | $6.01 | $100,343 |
| Aug 17, 2026 | AN2 Therapeutics Inc. | Open-market sale | −18,706 | $6.01 | $112,423 |
| Dec 19, 2024 | AN2 Therapeutics Inc. | Grant or award | +9,077 | — | — |
| Dec 10, 2024 | AN2 Therapeutics Inc. | Open-market purchase | +5,000 | $1.49 | $7,450 |
| Dec 10, 2024 | AN2 Therapeutics Inc. | Open-market purchase | +5,000 | $1.49 | $7,450 |
| Dec 9, 2024 | AN2 Therapeutics Inc. | Open-market purchase | +12,289 | $1.43 | $17,573 |
| Dec 9, 2024 | AN2 Therapeutics Inc. | Open-market purchase | +18,483 | $1.43 | $26,431 |
| Dec 6, 2024 | AN2 Therapeutics Inc. | Open-market purchase | +12,711 | $1.45 | $18,431 |
| Dec 6, 2024 | AN2 Therapeutics Inc. | Open-market purchase | +6,517 | $1.45 | $9,450 |
Questions about Robin Shane Readnour
What boards is Robin Shane Readnour on?
Robin Shane Readnour sits on the board of AN2 Therapeutics Inc.
How long has Robin Shane Readnour served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.